Skip to content

Legacy Giving: Support OCRA Through an Estate Plan

Estate Planning

Create a lasting legacy to fund future research and support programs by donating to The Teal Trust.

Ensure a Life-Saving Legacy

Including OCRA in your estate plan is an easy way to commit to funding crucial research for ovarian and related gynecologic cancers now and in the future.

Your lawyer or financial advisor can assist with either creating or adjusting your estate plans.

We recommend that your bequest be designated for unrestricted purposes or be directed to general research because we cannot predict future medical advances or the future of our patient support programs.

Need help creating an estate plan?

FreeWill, a secure online resource that we have partnered with, guides you through the process of making or updating a legally valid will and including a gift to OCRA. The entire process takes less than 20 minutes and is 100% free. This is an easy way to help patients and support survivors well into the future.

FreeWill can also help you easily plan beneficiaries for your non-probate assets (such as an IRA, 401(k), life-insurance policy, or any other assets not included in your will) in one place. You can even designate OCRA as a beneficiary of these kinds of assets if you choose.

Already made a gift to OCRA in your estate plan?

Please fill out this form to let us know so we can say thank you and update our records!

Email donations@ocrahope.org or call 212-268-1002 to notify us of your plans or for further information.

Related Topics

OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer

OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer

A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued

Read more

(Webinar) – Ask the Experts: Gynecologic Sarcoma

(Webinar) – Ask the Experts: Gynecologic Sarcoma

Watch Now: Ask the Experts Webinar on Gynecologic Sarcoma On January 28, 2026, Ovarian Cancer Research Alliance (OCRA) hosted a live Ask the Experts: Gynecologic Sarcoma webinar with Matthew Hemming, MD, PhD. Moderated by Liza Lundgren, LCSW, OCRA’s Director of Education, this free session featured a live discussion and audience Q&A focused on gynecologic sarcoma research, … Continued

Read more

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

The Congressional Appropriations Committees have released a combined FY2026  Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.